JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141754

D-erythro MAPP,alkaline ceramidase抑制剂

D-erythro MAPP, alkaline ceramidase inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 361.6 Da, Purity >98%. Specific inhibitor of alkaline ceramidase (IC50 = 1 μM). Elevates endogenous ceramide leading to growth suppression and cell cycle arrest. Inhibits acid ceramidase (IC50 = 500 μM). Cell-permeable. Active *in vitro*.

查看别名

AC, ACDase, ASAH, ASAH1_HUMAN, Acid CDase, Acid ceramidase, Acid ceramidase precursor, Acid ceramidase subunit beta, Acylsphingosine deacylase, FLJ21558, FLJ22079, N acylsphingosine amidohydrolase (acid ceramidase) 1, N acylsphingosine amidohydrolase 1, N-acylsphingosine amidohydrolase, N-acylsphingosine deacylase, PHP32, Putative 32 kDa heart protein, SMAPME

1 Images
Chemical Structure - D-erythro MAPP, alkaline ceramidase inhibitor (AB141754)
  • Chemical Structure

Lab

Chemical Structure - D-erythro MAPP, alkaline ceramidase inhibitor (AB141754)

2D chemical structure image of ab141754, D-erythro MAPP, alkaline ceramidase inhibitor

关键信息

CAS 号

60847-25-8

纯度

>98%

分子量

361.6 Da

分子式

C<sub>2</sub><sub>3</sub>H<sub>3</sub><sub>9</sub>NO<sub>2</sub>

PubChem

124735

属性

Synthetic

溶解度

Soluble in DMSO to 50 mM

Soluble in ethanol to 50 mM

生化试剂名称

D-erythro-MAPP

生物学描述

Specific inhibitor of alkaline ceramidase (IC50 = 1 μM). Elevates endogenous ceramide leading to growth suppression and cell cycle arrest. Inhibits acid ceramidase (IC50 = 500 μM). Cell-permeable. Active *in vitro*.

经典 SMILES

CCCCCCCCCCCCCC(=O)NC(C)C(C1=CC=CC=C1)O

同分异构的 SMILES

CCCCCCCCCCCCCC(=O)N[C@H](C)[C@H](C1=CC=CC=C1)O

InChi

InChI=1S/C23H39NO2/c1-3-4-5-6-7-8-9-10-11-12-16-19-22(25)24-20(2)23(26)21-17-14-13-15-18-21/h13-15,17-18,20,23,26H,3-12,16,19H2,1-2H3,(H,24,25)/t20-,23-/m1/s1

InChiKey

YLAZEWZHIRBZDA-NFBKMPQASA-N

IUPAC 名

N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]tetradecanamide

性能和储存信息

运输条件
Ambient - Can Ship with Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
Store under desiccating conditions|The product can be stored for up to 12 months

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

ASAH1 also known as acid ceramidase or alkaline ceramidase is an enzyme that plays a role in the hydrolysis of ceramides into sphingosine and free fatty acids. It has a mass of approximately 55 kDa. This enzyme is primarily found in lysosomes cellular organelles that manage waste. ASAH1 is expressed in various tissues including liver heart brain and skin illustrating its widespread distribution in the body.
Biological function summary

ASAH1 influences several important cellular processes by controlling the levels of ceramide and sphingosine. These lipids are not just structural components of membranes; they participate actively in cell signaling. ASAH1 exists as part of a larger complex that includes other enzymes involved in sphingolipid metabolism. Changes in ceramide levels influence apoptosis and cell proliferation indicating ASAH1's role as a regulator in these processes.

Pathways

ASAH1 is central to the sphingolipid metabolism pathway. This pathway is interconnected with the apoptosis signaling pathway. By converting ceramide to sphingosine ASAH1 links the complex ceramide/sphingosine balance affecting cell survival and death decisions. It interacts with other enzymes such as sphingosine kinase 1 and ceramide synthases which further maintain the dynamic regulation between sphingosine and ceramide levels.

ASAH1 is linked to conditions such as Farber disease and spinal muscular atrophy. These disorders result from dysfunctional ceramide metabolism causing cellular and systemic impacts due to excessive ceramide accumulation. Proteins like acid sphingomyelinase are related to ASAH1's role in these diseases as both contribute to sphingolipid balance in cells. Understanding ASAH1 and its pathways provides insights into potential therapeutic targets for these sphingolipid-related disorders.

产品实验方案

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com